Literature DB >> 25522898

Delights and let-downs in the management of tumor necrosis factor receptor-associated periodic syndrome: the canakinumab experience in a patient with a high-penetrance T50M TNFRSF1A variant.

Luca Cantarini1, Giuseppe Lopalco2, Antonio Vitale1, Francesco Caso1,3, Giovanni Lapadula2, Florenzo Iannone2, Mauro Galeazzi1, Donato Rigante4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25522898     DOI： 10.1111/1756-185X.12521

Source DB:  PubMed          Journal:  Int J Rheum Dis        ISSN： 1756-1841            Impact factor:   2.454


× No keyword cloud information.
  5 in total

Review 1.  Recurrent fever and arthralgia as the presentation of tumor necrosis factor receptor-associated periodic syndrome (TRAPS) in a Chinese girl: a case report and review of the literature.

Authors:  Yanxia Chen; Xingqi Huang; Sujie Zheng; Zhongliang Zhu; Wei Yang; Jinlin Liu
Journal:  Clin Rheumatol       Date:  2018-02-15       Impact factor: 2.980

2.  Non-response to Interleukin-1 Antagonist Canakinumab in Two Patients with Refractory Pyoderma Gangrenosum and Hidradenitis Suppurativa.

Authors:  Natalie Z Sun; Teresa Ro; Puneet Jolly; Christopher J Sayed
Journal:  J Clin Aesthet Dermatol       Date:  2017-09-01

Review 3.  Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases.

Authors:  Alessandra Bettiol; Giuseppe Lopalco; Giacomo Emmi; Luca Cantarini; Maria Letizia Urban; Antonio Vitale; Nunzio Denora; Antonio Lopalco; Annalisa Cutrignelli; Angela Lopedota; Vincenzo Venerito; Marco Fornaro; Alfredo Vannacci; Donato Rigante; Rolando Cimaz; Florenzo Iannone
Journal:  Int J Mol Sci       Date:  2019-04-17       Impact factor: 5.923

Review 4.  IL-1 Inhibitors in the Treatment of Monogenic Periodic Fever Syndromes: From the Past to the Future Perspectives.

Authors:  Hana Malcova; Zuzana Strizova; Tomas Milota; Ilja Striz; Anna Sediva; Dita Cebecauerova; Rudolf Horvath
Journal:  Front Immunol       Date:  2021-02-01       Impact factor: 7.561

Review 5.  Real-Life Indications of Interleukin-1 Blocking Agents in Hereditary Recurrent Fevers: Data From the JIRcohort and a Literature Review.

Authors:  Caroline Vinit; Sophie Georgin-Lavialle; Aikaterini Theodoropoulou; Catherine Barbier; Alexandre Belot; Manel Mejbri; Pascal Pillet; Jana Pachlopnik; Sylvaine Poignant; Charlotte Rebelle; Andreas Woerner; Isabelle Koné-Paut; Véronique Hentgen
Journal:  Front Immunol       Date:  2021-11-11       Impact factor: 7.561
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.